Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Torulopsis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1150 Breast Neoplasms 599 Carcinoma, Non-Small-Cell Lung 457 Lymphoma 383 Neoplasm Metastasis 376 Leukemia, Myeloid, Acute 370 Melanoma 342 Prostatic Neoplasms 328 Multiple Myeloma 317 Lymphoma, Non-Hodgkin 307 Ovarian Neoplasms 297 Pancreatic Neoplasms 281 Colorectal Neoplasms 281 Precursor Cell Lymphoblastic Leukemia-Lymphoma 277 Leukemia, Lymphocytic, Chronic, B-Cell 274 Leukemia 253 Unspecified Adult Solid Tumor, Protocol Specific 233 Lung Neoplasms 231 Glioblastoma 228 Recurrence 220 Lymphoma, Follicular 210 Brain Neoplasms 207 Lymphoma, Large B-Cell, Diffuse 205 Lymphoma, Mantle-Cell 178 Head and Neck Neoplasms 165 Hodgkin Disease 164 Carcinoma, Renal Cell 162 Myelodysplastic Syndromes 158 Stomach Neoplasms 151 Glioma 149

Interventions

PRA1 protein, Candida albicans 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00569231 2011-01-25

Study With Candida Antigen for Treatment of Warts

University of Arkansas

Phase 1 Completed

18 enrolled 8 charts

Torulopsis, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡